Li Ge - Net Worth and Insider Trading

Li Ge Net Worth

The estimated net worth of Li Ge is at least $10.5 Billion dollars as of 2024-12-14. Li Ge is the 2201 Interest of corporation controlled by you of WuXi Biologics (Cayman) Inc and owns about 590,257,633 shares of WuXi Biologics (Cayman) Inc (HKSE:02269) stock worth over $10.5 Billion. Details can be seen in Li Ge's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Li Ge has not made any transactions after 2024-03-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Li Ge

To

Li Ge Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Li Ge owns 1 companies in total, including WuXi Biologics (Cayman) Inc (HKSE:02269) .

Click here to see the complete history of Li Ge’s form 4 insider trades.

Insider Ownership Summary of Li Ge

Ticker Comapny Transaction Date Type of Owner
HKSE:02269 WuXi Biologics (Cayman) Inc 2024-03-28 2201 Interest of corporation controlled by you

Li Ge Latest Holdings Summary

Li Ge currently owns a total of 1 stock. Li Ge owns 590,257,633 shares of WuXi Biologics (Cayman) Inc (HKSE:02269) as of March 28, 2024, with a value of $10.5 Billion.

Latest Holdings of Li Ge

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:02269 WuXi Biologics (Cayman) Inc 2024-03-28 590,257,633 17.80 10,506,585,867

Holding Weightings of Li Ge


Li Ge Form 4 Trading Tracker

According to the SEC Form 4 filings, Li Ge has made a total of 8 transactions in WuXi Biologics (Cayman) Inc (HKSE:02269) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in WuXi Biologics (Cayman) Inc is the acquisition of 831,000 shares on March 28, 2024, which cost Li Ge around $12 Million.

Insider Trading History of Li Ge

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Li Ge Trading Performance

GuruFocus tracks the stock performance after each of Li Ge's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Li Ge is -37.71%. GuruFocus also compares Li Ge's trading performance to market benchmark return within the same time period. The performance of stocks bought by Li Ge within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Li Ge's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Li Ge

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -21.85 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -22.64 LIMIT LIMIT LIMIT LIMIT LIMIT

Li Ge Ownership Network

Ownership Network List of Li Ge

No Data

Ownership Network Relation of Li Ge

Insider Network Chart

Li Ge Owned Company Details

What does WuXi Biologics (Cayman) Inc do?

Who are the key executives at WuXi Biologics (Cayman) Inc?

Li Ge is the 2201 Interest of corporation controlled by you of WuXi Biologics (Cayman) Inc. Other key executives at WuXi Biologics (Cayman) Inc include 2201 Interest of corporation controlled by you BlackRock, Inc. , 2201 Interest of corporation controlled by you Jpmorgan Chase & Co. , and 2502 Approved lending agent Citigroup Inc. .

WuXi Biologics (Cayman) Inc (HKSE:02269) Insider Trades Summary

Over the past 18 months, Li Ge made 2 insider transaction in WuXi Biologics (Cayman) Inc (HKSE:02269) with a net purchase of 6,066,500. Other recent insider transactions involving WuXi Biologics (Cayman) Inc (HKSE:02269) include a net purchase of 101,089,124 shares made by Jpmorgan Chase & Co. , a net sale of 0 shares made by BlackRock, Inc. , and a net sale of 0 shares made by Citigroup Inc. .

In summary, during the past 3 months, insiders sold 0 shares of WuXi Biologics (Cayman) Inc (HKSE:02269) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 52,569,706 shares of WuXi Biologics (Cayman) Inc (HKSE:02269) were sold and 159,725,330 shares were bought by its insiders, resulting in a net purchase of 107,155,624 shares.

WuXi Biologics (Cayman) Inc (HKSE:02269)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

WuXi Biologics (Cayman) Inc Insider Transactions

No Available Data

Li Ge Mailing Address

Above is the net worth, insider trading, and ownership report for Li Ge. Currently GuruFocus does not have mailing address information for Li Ge.